Latest News
Asia report: Markets mostly lower as investors await Fed
Markets in Asia ended Tuesday mostly lower, ahead of the release of important US data later in the week, and as concern the Fed may raise interest rates at its April meeting continued.
Yahoo gives potential buyers deadline for bids
Yahoo has reportedly given bidders until 11 April to submit initial offers for its core web business and Asian assets.
Bidding war heats up as Anbang sweetens offer for Starwood
The bidding war for Starwood Hotels & Resorts heated up as a consortium led by Anbang Insurance Group lifted its offer for the company to $14bn, trumping Marriott International’s $13. 6bn.
Lamprell slides on Canaccord downgrade
UAE-based oil rig maker Lamprell was under the cosh after Canaccord Genuity cut its rating on the stock to ‘hold’ from ‘buy’ and slashed the price target to 95p from 150p saying the company’s transformation has stalled.
Deutsche Bank upgrades Next to 'buy'
Deutsche Bank upgraded Next to ‘buy’ from ‘hold’ but cut the price target to 6,850p from 7,200p following the company’s full year results last week.
London open: Stocks advance as trading resumes after Easter break
UK stocks gained on Tuesday as trading resumed following the Easter break and investors shrugged off negative session in Asia.
Europe open: Stocks in the black after Easter break
European stocks rose on Tuesday as traders got back to their desks following the long Easter weekend.
Tritax Big Box buys Argos distribution centre for £74m
Tritax Big Box REIT said it had bought the Burton-upon-Trent national distribution centre of retailer Argos for £74. 65m.
Depressed rouble keeps Polymetal strong
Polymetal swung into positive net earnings territory in 2015, with the Russian precious metals producer reporting solid numbers for the calendar year on Tuesday thanks to a seriously devalued rouble.
Lancashire Holdings secures $300m lending facility
Lancashire Holdings’ fully-owned subsidiary Lancashire Insurance Co Ltd has entered into a new $300m (£211m) five-year letter of credit and credit facility with Lloyds and Barclays Bank as joint bookrunners.
AG Barr looks to move away from sugary drinks as FY sales not so sweet
Soft drinks maker AG Barr said it was looking to move away from sugary drinks in response to the UK government's plans to introduce an extra tax on the products as it reported its full year results.
London pre-open: Stocks seen touch higher after Easter break
London stocks are set to open a touch higher on Tuesday as traders get back to their desks following the long Easter weekend.
AG Barr profit rises but revenue slips; Astra's Tagrisso approved in Japan
London’s FTSE 100 is seen starting six points higher than Friday’s close at 6,113.
Approval in Japan for AstraZeneca lung cancer treatment
The Japanese Ministry of Health, Labour and Welfare delivered good news to AstraZeneca on Tuesday morning, approving the FTSE 100 drug company's Tagrisso (osimertinib) tablets for the treatment of patients with epidermal growth factor receptor (EGFR) T790M mutation-positive inoperable or recurrent non-small cell lung cancer (NSCLC) that is resistant to EGFR tyrosine kinase inhibitor therapy.
Tuesday newspaper round-up: Apple, Starwood, pensions, HMRC
The FBI has abandoned its attempt to force Apple to help it break into the San Bernardino shooter’s iPhone, after it found another way to access the device’s contents without the company’s help. The move ends a high-stakes stand-off between the iPhone maker and the US government but leaves unresolved the wider issue of how far tech companies should be required to modify their products to aid law enforcement. In their respective statements, the Department of Justice left open the door to future legal clashes with Silicon Valley over encryption and data security, while Apple said it would continue to strengthen the protections built into its devices.
Glaxo Nucala asthma treatment approved for use in Japan
GlaxoSmithKline said Japan's Ministry of Health, Labour and Welfare has granted approval for Nucala as a treatment for bronchial asthma in patients with refractory asthma whose symptoms are inadequately controlled with standard treatment.